BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3002593)

  • 1. Contralateral cancerous breast lesions in women with clinical invasive breast carcinoma.
    Nielsen M; Christensen L; Andersen J
    Cancer; 1986 Mar; 57(5):897-903. PubMed ID: 3002593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axillary lymph node morphology in women with in situ breast carcinoma. An autopsy study.
    Nielsen M; Christensen L; Jensen J; Thomsen JL; Andersen JA
    Virchows Arch A Pathol Anat Histopathol; 1988; 412(4):347-55. PubMed ID: 3125673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of synchronous and metachronous bilateral breast cancer.
    Kollias J; Ellis IO; Elston CW; Blamey RW
    World J Surg; 2001 Sep; 25(9):1117-24. PubMed ID: 11571945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment and survival of female patients with nonpalpable breast carcinoma.
    Tinnemans JG; Wobbes T; Holland R; Hendriks JH; Van der Sluis RF; De Boer HH
    Ann Surg; 1989 Feb; 209(2):249-53. PubMed ID: 2537064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance and staging of nonpalpable carcinomas of the breast.
    Schwartz GF; Feig SA; Patchefsky AS
    Surg Gynecol Obstet; 1988 Jan; 166(1):6-10. PubMed ID: 2827328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of intraductal multicentric breast carcinoma with bilateral axillary metastases].
    Vidu V; Hortopan M; Aldea C; Liscu B; Popovici A
    Chirurgia (Bucur); 2000; 95(6):543-7. PubMed ID: 14870533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of subsequent contralateral breast carcinoma in a population of patients with in-situ breast carcinoma.
    Webber BL; Heise H; Neifeld JP; Costa J
    Cancer; 1981 Jun; 47(12):2928-32. PubMed ID: 6266644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit.
    Moore KH; Sweeney KJ; Wilson ME; Goldberg JI; Buchanan CL; Tan LK; Liberman L; Turner RR; Lagios MD; Cody Iii HS; Giuliano AE; Silverstein MJ; Van Zee KJ
    Ann Surg Oncol; 2007 Oct; 14(10):2911-7. PubMed ID: 17597346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option.
    Haberer S; Belin L; Le Scodan R; Kirova YM; Savignoni A; Stevens D; Moisson P; Decaudin D; Pierga JY; Reyal F; Campana F; Fourquet A; Bollet MA
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e145-52. PubMed ID: 21605948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel lymph node biopsy in breast cancer New indications and our experience.
    Zanghì G; Rinzirillo NM; Caponnetto AM; Vecchio R; Catania V; Leanza V
    Ann Ital Chir; 2015; 86():508-12. PubMed ID: 26898363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilateral and multifocal breast carcinoma. A clinical and autopsy study with special emphasis on carcinoma in situ.
    Ringberg A; Palmer B; Linell F; Rychterova V; Ljungberg O
    Eur J Surg Oncol; 1991 Feb; 17(1):20-9. PubMed ID: 1847343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No impact of breast magnetic resonance imaging on 15-year outcomes in patients with ductal carcinoma in situ or early-stage invasive breast cancer managed with breast conservation therapy.
    Vapiwala N; Hwang WT; Kushner CJ; Schnall MD; Freedman GM; Solin LJ
    Cancer; 2017 Apr; 123(8):1324-1332. PubMed ID: 27984658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimal breast cancer: a clinical appraisal.
    Peters TG; Donegan WL; Burg EA
    Ann Surg; 1977 Dec; 186(6):704-10. PubMed ID: 203233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lobular carcinoma in situ (LCIS) of the breast: is long-term outcome similar to ductal carcinoma in situ (DCIS)? Analysis of 200 cases.
    Cutuli B; De Lafontan B; Kirova Y; Auvray H; Tallet A; Avigdor S; Brunaud C; Delva C
    Radiat Oncol; 2015 May; 10():110. PubMed ID: 25944033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axillary lymph node dissection in pT1 breast cancer: a retrospective analysis of 315 patients and review of the literature.
    Witt A; Obwegeser R; Auerbach L; Tempfer C; Yavuz D; Kubista E
    Wien Klin Wochenschr; 2002 Jun; 114(10-11):387-90. PubMed ID: 12708092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reappraisal of internal mammary node metastases as a prognostic factor in patients with breast cancer.
    Noguchi M; Ohta N; Koyasaki N; Taniya T; Miyazaki I; Mizukami Y
    Cancer; 1991 Nov; 68(9):1918-25. PubMed ID: 1655229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinoma in situ of the breast.
    Carter D; Smith RR
    Cancer; 1977 Sep; 40(3):1189-93. PubMed ID: 198088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies.
    Nielsen M; Thomsen JL; Primdahl S; Dyreborg U; Andersen JA
    Br J Cancer; 1987 Dec; 56(6):814-9. PubMed ID: 2829956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symmetrization reduction mammaplasty combined with sentinel node biopsy in patients operated for contralateral breast cancer.
    Schrenk P; Wölfl S; Bogner S; Huemer GM; Wayand W
    J Surg Oncol; 2006 Jul; 94(1):9-15. PubMed ID: 16788937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of microcalcifications without palpable mass in the diagnosis of breast cancer.
    Tinnemans JG; Wobbes T; Lubbers EJ; van der Sluis RF; de Boer HH
    Surgery; 1986 Jun; 99(6):652-7. PubMed ID: 3012811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.